Tue. 27 Feb 2024, 5:40pm ET
Benzinga
Earnings, Earnings Beats, News
Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of undefined by Infinity percent. The company reported quarterly sales of $60.00 million which beat the analyst consensus estimate of $40.00 million by 50.00 percent.